Sciencast Management LP Boosts Holdings in Bath & Body Works, Inc. $BBWI

Key Points

• Sciencast Management LP increased its stake in Bath & Body Works by 48.9%, now owning approximately 0.05% of the company valued at $3.5 million.
• Bath & Body Works reported earnings of $0.37 EPS, meeting analysts' expectations, with a net margin of 9.88% and a projected fiscal year 2025 EPS ranging between 3.350-3.600.
• The company has announced a quarterly dividend of $0.20, resulting in an annualized yield of 2.7% and a payout ratio of 23.74%.

Sciencast Management LP boosted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 48.9% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 116,219 shares of the company's stock after purchasing an additional 38,183 shares during the period. Sciencast Management LP owned approximately 0.05% of Bath & Body Works worth $3,524,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Northwest Bank & Trust Co grew its position in Bath & Body Works by 2.9% during the 4th quarter. Northwest Bank & Trust Co now owns 14,700 shares of the company's stock worth $533,000 after purchasing an additional 419 shares during the last quarter. Blue Trust Inc. raised its position in Bath & Body Works by 15.5% during the 1st quarter. Blue Trust Inc. now owns 4,184 shares of the company's stock worth $127,000 after buying an additional 560 shares during the last quarter. UMB Bank n.a. raised its position in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company's stock worth $46,000 after buying an additional 596 shares during the last quarter. Natixis Advisors LLC raised its position in Bath & Body Works by 0.7% during the 1st quarter. Natixis Advisors LLC now owns 90,089 shares of the company's stock worth $2,732,000 after buying an additional 629 shares during the last quarter. Finally, Golden State Wealth Management LLC raised its position in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company's stock worth $40,000 after buying an additional 642 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Down 7.5%

Shares of NYSE BBWI opened at $29.49 on Monday. The stock has a market cap of $6.08 billion, a price-to-earnings ratio of 8.75, a PEG ratio of 1.01 and a beta of 1.49. Bath & Body Works, Inc. has a 52 week low of $24.94 and a 52 week high of $41.87. The company's 50-day moving average price is $30.73 and its 200 day moving average price is $30.45.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings data on Thursday, August 28th. The company reported $0.37 EPS for the quarter, meeting analysts' consensus estimates of $0.37. The firm had revenue of $1.55 billion for the quarter, compared to analysts' expectations of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The firm's revenue was down .8% on a year-over-year basis. During the same period in the prior year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, research analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Stockholders of record on Friday, August 22nd were given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Friday, August 22nd. Bath & Body Works's payout ratio is currently 23.74%.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Barclays upped their price objective on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an "equal weight" rating in a research report on Friday, August 29th. The Goldman Sachs Group cut their price objective on shares of Bath & Body Works from $44.00 to $43.00 and set a "buy" rating for the company in a research report on Friday, May 30th. Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the stock an "overweight" rating in a research report on Thursday, May 15th. Wall Street Zen downgraded shares of Bath & Body Works from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Finally, JPMorgan Chase & Co. upped their price target on shares of Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Twelve research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $41.62.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.

Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.